| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |